Gamida Cell Ltd. (NASDAQ:GMDA) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to Gamida Cells Conference Call for Third Quarter 2023 Financial Results.
Source: insidermonkey.com
📰 Global Randomized Phase News
Global Randomized Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Global Randomized Phase. Real-time updates on events, politics, business and more.
FDA Accepts BioMarin's Supplemental New Drug Application to Expand Use of VOXZOGO® (vosoritide) for Injection to Treat Children with Achondroplasia Under the Age of 5
/PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery,...
Source: prnewswire.com
European Medicines Agency Validates Application for Extension of Indication for VOXZOGO® (vosoritide) for injection to Treat Children with Achondroplasia Under the Age of 2
/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery,...
Hank Fuchs Traci Mccarty European Commission Drug Administration Biomarin Pharmaceutical Inc Exchange Commission
Source: prnewswire.com
European Medicines Agency Validates Application for Extension of Indication for VOXZOGO® (vosoritide) for injection to Treat Children with Achondroplasia Under the Age of 2
/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery,...
Hank Fuchs Traci Mccarty European Commission Drug Administration Biomarin Pharmaceutical Inc Exchange Commission
Source: prnewswire.com
Gamida Cell Announces Data to be Presented at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com